0000927066-24-000034.txt : 20240308 0000927066-24-000034.hdr.sgml : 20240308 20240308170452 ACCESSION NUMBER: 0000927066-24-000034 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240306 FILED AS OF DATE: 20240308 DATE AS OF CHANGE: 20240308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ACKERMAN JOEL CENTRAL INDEX KEY: 0001220630 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14106 FILM NUMBER: 24735413 MAIL ADDRESS: STREET 1: COVENTRY HEALTH CARE, INC. STREET 2: 6705 ROCKLEDGE DR SUITE 900 CITY: BETHESDA STATE: MD ZIP: 20817 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DAVITA INC. CENTRAL INDEX KEY: 0000927066 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 510354549 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 310-536-2668 MAIL ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC. DATE OF NAME CHANGE: 20121107 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA INC DATE OF NAME CHANGE: 20001005 FORMER COMPANY: FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC DATE OF NAME CHANGE: 19950524 4 1 wk-form4_1709935481.xml FORM 4 X0508 4 2024-03-06 0 0000927066 DAVITA INC. DVA 0001220630 ACKERMAN JOEL C/O DAVITA INC. 2000 16TH STREET DENVER CO 80202 0 1 0 0 CFO and Treasuer 0 Common Stock 2024-03-06 4 M 0 55000 52.41 A 195360 D Common Stock 2024-03-06 4 D 0 21408 134.65 D 173952 D Common Stock 2024-03-06 4 F 0 17149 134.65 D 156803 D Stock Appreciation Rights 52.41 2024-03-06 4 M 0 55000 0 D 2022-06-20 2024-06-20 Common Stock 55000 0 D Represents the shares withheld in payment of the base price in connection with the exercise of Stock Appreciation Rights reported on this Form 4. Represents the shares withheld to satisfy the tax withholding obligation in connection with the exercise of Stock Appreciation Rights reported on this Form 4. The Stock Appreciation Rights were granted on June 20, 2019, which vested 50% each on June 20, 2022 and June 20, 2023. /s/ Stephanie N. Berberich, Attorney-in-Fact 2024-03-08